⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12029062 | 0.93 | CYP4F2 (0.32) | — | |
| SCHEMBL12059903 | 0.91 | CYP4F2 (0.35) | — | |
| SCHEMBL713166 | 0.84 | — | — | |
| SCHEMBL12045190 | 0.80 | CYP4F2 (0.30) | — | |
| SCHEMBL12045209 | 0.80 | CYP4F2 (0.30) | — | |
| SCHEMBL3161578 | 0.77 | HSD17B10 (0.31) | — | |
| SCHEMBL10710604 | 0.76 | ALDH1A1 (0.34) | — | |
| SCHEMBL253950 | 0.75 | — | — | |
| SCHEMBL8566999 | 0.75 | — | — | |
| SCHEMBL18322828 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113816841-A | Preparation method of cyclopropyl methyl ketone | 瑞孚信江苏药业股份有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-4990682-A | Ketalization, distillation, hydrogenation | HUELS AG (DE) | 1991-02-05 | — | — | US | claimed |
| EP-0380783-A2 | Method for the preparation of 5-chloro-pentan-2-one | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-08-08 | — | — | EP | claimed |
| JP-2235835-A | — | — | None | — | — | JP | disclosed |
| CN-113816841-A | Preparation method of cyclopropyl methyl ketone | 瑞孚信江苏药业股份有限公司 | 2021-12-21 | — | — | CN | disclosed |
| CN-113816841-A | Preparation method of cyclopropyl methyl ketone | 瑞孚信江苏药业股份有限公司 | 2021-12-21 | — | — | CN | disclosed |
| US-9045403-B2 | Geranyl geranyl acetone (GGA) derivatives and compositions thereof | COYOTE PHARMACEUTICALS, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-9045403-B2 | Geranyl geranyl acetone (GGA) derivatives and compositions thereof | COYOTE PHARMACEUTICALS, INC. (US) | 2015-06-02 | — | — | US | disclosed |
| US-20150133431-A1 | GGA DERIVATIVES | COYOTE PHARMACEUTICALS, INC. (US) | 2015-05-14 | — | — | US | disclosed |
| US-20150133431-A1 | GGA DERIVATIVES | COYOTE PHARMACEUTICALS, INC. (US) | 2015-05-14 | — | — | US | disclosed |
| US-20150025077-A1 | GGA AND GGA DERIVATIVES COMPOSITIONS THEREOF AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES INCLUDING PARALYSIS INCLUDING THEM | COYOTE PHARMACEUTICALS, INC. (US) | 2015-01-22 | — | — | US | disclosed |
| US-6403789-B1 | REACTING IN ORGANIC SOLVENT DIALKYLHALOIMINIUM COMPOUND AS HALOGENATING AGENT AND LOWER ALKYL SULFONE, LOWER ALKENYL SULFONE, ARYL SULFONE OR HETEROCYCLIC SULFONE WITH HYDROXYL GROUP CONTAINING COMPOUND TO OBTAIN HALOGENIDE | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2002-06-11 | — | — | US | disclosed |
| US-6194567-B1 | PURITY OF HALOGENATED PRODUCT | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2001-02-27 | — | — | US | disclosed |
| EP-0976700-A1 | HALOGENATING AGENT AND PROCESS FOR HALOGENATING HYDROXYL GROUP | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 2000-02-02 | — | — | EP | disclosed |
| EP-0380783-A3 | METHOD FOR THE PREPARATION OF 5-CHLORO-PENTAN-2-ONE | HÜLS AKTIENGESELLSCHAFT (DE) | 1992-03-18 | — | — | EP | disclosed |
| US-4990682-A | Ketalization, distillation, hydrogenation | HUELS AG (DE) | 1991-02-05 | — | — | US | disclosed |
| US-4990682-A | Ketalization, distillation, hydrogenation | HUELS AG (DE) | 1991-02-05 | — | — | US | disclosed |
| JP-H02235835-A | PREPARATION OF 5-CHLORO-2-PENTANONE | HUELS AG | 1990-09-18 | — | — | JP | disclosed |
| EP-0380783-A2 | Method for the preparation of 5-chloro-pentan-2-one | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-08-08 | — | — | EP | disclosed |
| EP-0380783-A2 | Method for the preparation of 5-chloro-pentan-2-one | HÜLS AKTIENGESELLSCHAFT (DE) | 1990-08-08 | — | — | EP | disclosed |